The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for D Watson


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of a Series of Pyrrolopyridone MAT2A Inhibitors.EBI
AstraZeneca
Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors.EBI
Astrazeneca
Optimization of a series of potent, selective and orally bioavailable SYK inhibitors.EBI
Astrazeneca
Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinase.EBI
Astrazeneca
2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.EBI
Warner-Lambert
Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.EBI
Biota Holdings